RANI Rani Therapeutics Inc Total Asset Value of Company

Rani Therapeutics (RANI) is developing innovative "robo-pills" to replace injections and plans to monetize its patents through licensing agreements. The company is currently implementing automated production lines for RaniPill gastrointestinal systems that operate without personnel. This chart of total assets, with a value of 38.87, complements the business analysis. A California plant featuring robotic assembly and a stockpile of imported microchips serves as the foundation of its stability.

RANI (Rani Therapeutics Holdings, Inc.) Company Total Assets history from 07/04/2022 to 10/30/2026

Analytical breakdowns and data insights for company ranitherapeutics.com (RANI)

- current quotes and average value forecast:

Market Chart Rani Therapeutics Holdings, Inc.|RANI - Price Target Chart

- market capitalization data:

Market Valuation RANI|RANI - Enterprise Value

- issuer book value statistics:

Accounting Value of a Share Rani Therapeutics|RANI - Book Capitalization|Market Capitalization to Book Value Ratio ranitherapeutics.com|RANI - Aggregate Company Assets

- debt burden and liquidity indicators:

All Debt to Shareholders' Equity Ratio Rani Therapeutics|RANI - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Rani Therapeutics Holdings, Inc.|RANI - Company Aggregate Debts|Debts to Book Capitalization RANI|RANI - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Rani Therapeutics|Immediate Liquidity ranitherapeutics.com

- net income and valuation multiples indicators:

RANI - Net Income

Fundamental valuation:Rani Therapeutics

Manufactured products of Rani Therapeutics Holdings

To identify fundamental benchmarks, it is critical for investors to track the resource dynamics of Rani Therapeutics (RANI), calculated reversely via daily ROA to forecast the market value of assets. By analyzing fluctuations in assets and resources, one can assess how the capitalization of the unique RaniPill robotic biologic delivery technology transforms into actual base value, strengthening the patent advantage when engaging with pharmaceutical behemoths.

Key competitors

HLN - Company Total Asset Base|Aggregate Company Assets Kenvue|Verona Pharma PLC - Total Asset Value of Company|Company Total Assets MENS|LGND (Ligand Corp) - Aggregate Asset Value|Company Total Assets AMRX (Amneal Pharmaceuticals)|Company Total Assets perrigo.com PRGO|ALVO - Aggregate Company Assets|Aggregate Asset Value LQDA (Liquidia Corp)|Galapagos Genomics (GLPG) - Aggregate Company Assets|Cumulative Company Assets ANI Pharmaceuticals Corp|MNKD (MannKind Corporation) - Company Total Assets|Company Total Assets amphastar.com|Cumulative Company Assets PCRX (Pacira BioSciences, Inc.)|SPRY (ARS Pharmaceuticals Inc) - Aggregate Asset Value|Aggregate Company Assets Theravance TBPH|Aquestive Corp (AQST) - Company Assets|SCPH: Cumulative Company Assets|Tectonic Therapeutic, Inc. - Aggregate Business Assets|TNXP: Company Total Assets|China SXT Pharmaceuticals, Inc. - Aggregate Asset Value|EPRX (Eupraxia Pharmaceuticals, Inc.) - Company Total Assets|Company Assets BioHarvest Sciences Inc BHST|Aggregate Company Assets eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Aggregate Asset Value|Aggregate Company Assets Entera Bio ENTX|Aggregate Asset Value HYFT|ABVC BioPharma Inc - Company Total Assets|CPIX - Company Total Assets|Quantum BioPharma Ltd (QNTM) - Aggregate Company Assets|Total Business Assets FGEN|TELO (Telomir Pharmaceuticals, Inc.) - Company Total Assets|Synergy CHC Corporation (SNYR) - Company Total Asset Base|Cumulative Company Assets RLYB (Rallybio Corporation)|LEXX (lexariabioscience.com) - Aggregate Asset Value|Pulmatrix, Inc. - Cumulative Company Assets|Aggregate Business Assets PTHL (Pheton Holdings Limited)|Aptorum - Company Total Assets|Aggregate Asset Value LYRA (Lyra Therapeutics Inc.)|IBO: Company Total Assets|Company Assets TNF Pharmaceuticals, Inc. (TNFA)|Aggregate Company Assets cbdMD Inc.|PRFX: Aggregate Asset Value|Company Total Assets CYTO|Company Total Assets Lipella Pharmaceuticals Inc (LIPO)|Aggregate Company Assets Optinose OPTN|PIRS (Pieris Pharma) - Total Asset Value of Company|Procaps Group S.A. - Company Total Assets|Company Assets petrospharma.com|QLI (Qilian International Holding) - Cumulative Company Assets|Acelyrin Inc. (SLRN) - Company Total Assets|Cumulative Company Assets TFFP